Core Insights - The Chinese cosmetics market is undergoing a significant paradigm shift, moving from "scale expansion" to "quality leadership" as it surpasses a market size of 1 trillion yuan and domestic brands exceed international ones in sales [1] - HBN, a skincare brand that has filed for an IPO in Hong Kong, exemplifies this shift by focusing on "slow research-driven efficacy," providing a model for domestic brands aiming for high-end market penetration [1] Group 1: Market Trends - The transition of domestic cosmetics brands to high-end positioning is a notable trend, involving upgrades in brand positioning, product efficacy, and consumer perception [4] - HBN has capitalized on the rise of ingredient-focused consumers and the popularization of scientific skincare, playing a dual role in market education and category definition [4] Group 2: HBN's Product Development - HBN has pioneered the "early C, late A" skincare formula, launching successful products like the dual retinol night cream and brightening water, establishing itself in the high-end retinol market [5] - The brand's retinol skincare products and α-arbutin essence have ranked first in national sales for three consecutive years from 2022 to 2024, with cumulative sales of over 30 million units by the end of 2025 [5] Group 3: Consumer Engagement - HBN has accumulated over 4.6 million high-repeat purchase users, with average transaction values gradually increasing; its repurchase rates on platforms like Tmall and Douyin are approximately 35.4% and 44.0%, respectively [7] Group 4: Research and Development - HBN's commitment to "slow research" has built a systematic innovation capability, driving the brand towards high-end positioning [8] - The company has established a complete research loop from basic research to raw material innovation and efficacy verification, with a research team of 103 professionals across various fields [8][10] - HBN has published over 50 international SCI papers, ranking first among domestic skincare brands in terms of publications as the first author [8] Group 5: Efficacy Verification and Industry Contribution - HBN has developed a comprehensive "full-link multi-dimensional cross-validation system" for product efficacy, being the only Chinese skincare brand to conduct efficacy testing through international authoritative institutions [10] - The brand is also advocating for the establishment of a scientific evaluation system for cosmetic efficacy evidence, marking its transition from a market participant to a contributor to high-quality industry development [10] - This shift signifies HBN's role in defining industry standards and its commitment to high-end brand development through continuous investment in research and innovation [10]

Core Viewpoint - HBN has established itself as a leading domestic skincare brand in China, particularly known for its effective retinol products and the "early C, late A" skincare philosophy, and is now seeking to go public on the Hong Kong Stock Exchange [1][3]. Group 1: Brand Development and Market Position - HBN was founded in 2019 and chose to focus on the challenging retinol market, which was dominated by international brands, by emphasizing ingredient transparency and authoritative evidence [3][4]. - The brand has successfully positioned itself in the market by introducing a comprehensive product line that includes retinol-based skincare products, achieving the highest sales in its category from 2022 to 2024 [4][6]. Group 2: Research and Development Strategy - HBN has invested heavily in R&D and established a comprehensive verification system to ensure that all product claims are backed by clinical data, making it the only Chinese skincare brand to conduct efficacy testing through international authorities [6][7]. - The company has developed a sustainable innovation system that allows for the efficient reuse of research outcomes, leading to the continuous launch of new products and categories [7][9]. Group 3: Financial Performance and User Engagement - As of September 2025, HBN has accumulated over 4.6 million repeat customers, with average repurchase rates of approximately 35.4% on Tmall and 44.0% on Douyin, significantly higher than industry averages [10]. - Financially, HBN reported total revenue of 2.083 billion yuan in 2024, with net profit rising to 129 million yuan, and a 190.3% year-on-year increase in net profit for the first three quarters of 2025 [10].

Group 1 - The core viewpoint of the article highlights the milestone of Shenzhen reaching 600 listed companies, showcasing the strong capital vitality of the Shenzhen market, particularly in the hard technology sector [1] - HBN, a skincare brand focusing on efficacy, has submitted its listing application to the Hong Kong Stock Exchange, representing a new addition to Shenzhen's innovative landscape [1][10] - HBN's founder, Yao Zhenan, has a background in both technology and aesthetics, which has influenced the brand's commitment to genuine efficacy in skincare [3] Group 2 - HBN has established itself as a pioneer in the A-retinol anti-aging segment, with its products ranking first in sales within the category for three consecutive years from 2022 to 2024 [4] - The brand is recognized as the youngest among the top ten domestic skincare brands in China, and it leads the market for improvement-oriented skincare products [4] - HBN's research team consists of 103 members with expertise in various fields, contributing to its innovative product development and industry-leading results [6] Group 3 - HBN is the only skincare brand in China that has undergone efficacy testing by an international authority for its entire product line, reinforcing its commitment to genuine efficacy [8] - The brand has accumulated over 4.6 million repeat customers, with average repurchase rates on platforms like Tmall and Douyin significantly exceeding industry averages [8] - Financially, HBN achieved total revenue of 2.083 billion yuan in 2024, with net profit rising to 129 million yuan, indicating a healthy growth trajectory [9] Group 4 - HBN's upcoming listing on the Hong Kong Stock Exchange marks a new development phase, leveraging its commitment to rigorous research and user trust to set a differentiated path in the beauty and broader consumer sectors [10]

作者：新消费主张/cici 近日，HBN母公司，即深圳护家科技（集团）股份有限公司（简称"护家科技"）向港交所主板递交上市 申请书，摩根士丹利与中金公司为联席保荐人。据招股书，护家科技此次募集资金主要用于投入研发及 产品创新，加强生产能力，提升办公环境及增强数字化运营能力，投资品牌和市场推广，全渠道销售网 络的深化拓展等。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 出品：新浪财经上市公司研究院 2019年，功效护肤品牌HBN诞生，主打"早C晚A"的护肤理念，同年推出首款核心产品α-熊果素精萃 水。所谓"早C晚A"，即早上用含有维生素C成分的护肤品提亮，晚上用含有A醇成分护肤品抗衰老。 HBN的产品分为改善型护肤品与维稳型护肤品两大类，前者主要针对皱纹、色素沉淀、暗沉等肌肤老 化及氧化损伤，后者则主要满足日常护肤需求，包括清洁、维护健康皮肤屏障及紫外线防护等。具体来 看，旗下产品包括御龄紧致系列、美白焕亮系列、修护保湿系列、基础护肤系列、控油祛痘系列五大产 品线，建议零售价介于129元至689元之间。截至2025年9月30日，品牌共有36个SPU。 2023年、2024年及202 ...

Core Viewpoint - Shenzhen Hujia Technology (Group) Co., Ltd. has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with its brand HBN being a leading domestic skincare brand advocating the "early C, late A" skincare concept, and spending over 1 billion yuan annually on promotions [1][4]. Financial Performance - The company's revenue for the years 2023, 2024, and the first three quarters of 2025 were 1.948 billion yuan, 2.083 billion yuan, and 1.514 billion yuan respectively, with net profits of 39 million yuan, 129 million yuan, and 145 million yuan, and gross profit margins of 76.6%, 73.4%, and 75.3% [4]. - Revenue primarily comes from "improvement-type skincare products" and "stabilizing-type skincare products," with the former accounting for 78.3% to 81.8% of total revenue during the reporting period [4]. Business Model - The company heavily relies on a single brand, HBN, with its core growth driven by the market performance of concepts like "early C, late A" [4]. - Online sales channels accounted for 98.6%, 98.7%, and 95.1% of total sales during the reporting periods, indicating a strong dependence on e-commerce [4]. Inventory Management - The company's inventory at the end of each reporting period was 140 million yuan, 178 million yuan, and 180 million yuan, with inventory turnover days increasing from 113 days to 130 days, showing a significant upward trend [4]. Marketing and Promotion - Sales and distribution expenses were 1.268 billion yuan, 1.238 billion yuan, and 871 million yuan, representing 65.1%, 59.4%, and 57.6% of total revenue during the respective periods [7]. - The company emphasizes the need for effective brand, market, and marketing strategies to attract and retain consumers, leveraging social media and KOLs for promotion [7]. Shareholding Structure - The founder, Yao Zhenan, and his wife control 76.19% of the voting rights in the company, with Yao holding 35.08% directly and an additional 19.51% through proxy arrangements [9][11]. - The company declared a cash dividend of 100 million yuan prior to its listing application, with nearly 50 million yuan expected to benefit the controlling couple [11] Use of Proceeds - The funds raised from the listing will be used for R&D and product innovation, enhancing production capacity, improving office environments, boosting digital operations, investing in brand and market promotion, and general corporate purposes [12].

Core Viewpoint - HBN, a domestic skincare brand, has gained significant popularity among young consumers with its "early C, late A" concept and is preparing for an IPO to become the first publicly listed company in the domestic efficacy skincare sector, although it faces challenges related to high marketing costs and low R&D investment [1][2][4]. Company Performance - Shenzhen Hujia Technology (Group) Co., Ltd., the parent company of HBN, reported revenues of 1.948 billion yuan, 2.083 billion yuan, and 1.514 billion yuan for the years 2023, 2024, and the first nine months of 2025, respectively, with a year-on-year growth of 6.9% in 2024 and an increase of 10.2% in the first nine months of 2025 [2]. - The net profit showed explosive growth, with figures of 38.835 million yuan, 129 million yuan, and 145 million yuan for the same periods, reflecting a year-on-year increase of 232.5% in 2024 and a 190.3% increase in the first nine months of 2025 compared to the entire year of 2024 [2]. Market Position - The Chinese dermatological skincare market is experiencing a compound annual growth rate (CAGR) of 16.7% from 2019 to 2024, significantly outpacing the overall skincare market growth of approximately 8.6% [4]. - HBN ranks first among domestic brands in both improvement skincare products and dermatological skincare segments, with its core product "glow water" consistently leading the domestic essence water category [4]. Customer Engagement - As of September 2025, HBN has accumulated over 4.6 million repeat customers, with average repurchase rates of 35.4% on Tmall and 44% on Douyin, indicating strong customer loyalty [4]. Marketing and Sales Expenses - Hujia Technology's sales and distribution expenses have been rising, with figures of 1.267 billion yuan, 1.238 billion yuan, and 871 million yuan for 2023, 2024, and the first three quarters of 2025, respectively, accounting for 65.1%, 59.4%, and 57.6% of total revenue [4][6]. - Promotion expenses, which include advertising on e-commerce platforms and KOL/KOC fees, are the largest expenditure, amounting to approximately 1.048 billion yuan, 721 million yuan, and 720 million yuan during the same periods, representing 57.2%, 50.4%, and 47.6% of total revenue [6]. R&D and Product Complaints - Despite its strong market performance, Hujia Technology's R&D investment is relatively low, with R&D expenses of 65.979 million yuan, 57.834 million yuan, and 39.981 million yuan, leading to a decline in R&D expense ratio from 3.4% to 2.64%, which is below the industry average [10]. - The company has faced consumer complaints, with 948 reported cases on Black Cat Complaints, primarily concerning false advertising and allergic reactions, raising concerns about its "allergy-free guarantee" service [11][15]. Founder's Background and Shareholder Structure - The founder, Yao Zhenan, transitioned from academia to entrepreneurship, initially launching a sanitary napkin brand before entering the skincare market with HBN in 2019, focusing on anti-aging products [16][18]. - Meitu, the largest external shareholder, holds a 23.81% stake in Hujia Technology, and the company has announced a cash dividend plan of 100 million yuan ahead of its IPO [19][21].

Core Viewpoint - HBN, a rising skincare brand in China, is preparing for an IPO on the Hong Kong Stock Exchange, aiming to capitalize on the growing trend of domestic consumer brands going public [1][2]. Company Overview - HBN, founded in 2019, focuses on effective skincare products, particularly promoting the "Morning C, Evening A" concept, which emphasizes using vitamin C in the morning and retinol at night [2][4]. - The brand has quickly gained popularity, becoming one of the youngest brands in the top ten domestic skincare market, achieving significant sales growth within a short period [1][4]. Financial Performance - HBN's revenue reached approximately 19.48 billion RMB in 2023, with projections of 20.8 billion RMB in 2024 and 15.14 billion RMB for the first three quarters of 2025 [8]. - The net profit for the same periods was 38.8 million RMB, 129 million RMB, and 145 million RMB, indicating a substantial increase in net profit margin from 1.9% to 9.6% [8]. - The brand's average repurchase rates on platforms like Tmall and Douyin are around 35.4% and 44.0%, respectively, with over 4.6 million cumulative repurchase users [8]. Product and Market Position - HBN's product lines include anti-aging and daily skincare products, with prices ranging from 129 RMB to 689 RMB [6]. - The brand is ranked fourth among domestic mid-to-high-end skincare brands and is the largest domestic brand in the improvement skincare segment [8]. Business Structure and Risks - HBN's revenue is heavily reliant on a few key products, which accounted for nearly 40% of sales, raising concerns about business sustainability [9]. - The company has a high concentration of online sales, with online revenue accounting for over 95% in recent years, indicating limited diversification in sales channels [9][10]. Investment and Shareholding - Prior to the IPO, HBN's founders held a combined 76.19% voting power, with significant external investment from Meitu, which holds 23.81% of the shares [5]. - The company recently declared a cash dividend of 100 million RMB, with a portion already paid out, benefiting the founders significantly [5]. Industry Context - The trend of consumer brands going public in Hong Kong is accelerating, with numerous companies filing for IPOs, indicating a competitive environment for HBN [12][13]. - The Hong Kong Stock Exchange is experiencing a surge in IPO applications, with over 350 companies in the queue, highlighting the urgency for HBN to finalize its listing [16].

Core Viewpoint - HBN, a rising skincare brand in China, is preparing for an IPO on the Hong Kong Stock Exchange, aiming to capitalize on the current trend of domestic consumer brands going public [4][5]. Company Overview - HBN's parent company, Shenzhen Hujia Technology (Group) Co., Ltd., has submitted its IPO application, with Morgan Stanley and CICC as joint sponsors [4]. - Founded by a couple from Guangdong, HBN has quickly gained popularity in the skincare market, particularly with its "Morning C, Evening A" skincare philosophy [5][7]. - The brand has achieved significant revenue growth, entering the 2 billion to 4 billion RMB revenue tier within four years of its establishment [7][12]. Financial Performance - HBN's revenue for the first three quarters of 2023, 2024, and 2025 was 1.948 billion, 2.082 billion, and 1.373 billion RMB respectively, with net profits of 38.8 million, 129 million, and 145 million RMB, showing a net profit margin increase from 1.9% to 9.6% [12][14]. - The brand's product lines include both improvement-type and maintenance-type skincare products, with the former accounting for approximately 80% of revenue [12][13]. Market Position - HBN ranks fourth among domestic mid-to-high-end skincare brands in China, and it is the largest domestic brand in the improvement-type skincare market [12]. - The brand's average repurchase rates on platforms like Tmall and Douyin are approximately 35.4% and 44.0%, respectively, indicating strong customer loyalty [12]. Business Structure and Risks - HBN's revenue is heavily reliant on a few key products, which accounted for nearly 40% of sales, raising concerns about business vulnerability [13]. - The company's sales channels are predominantly online, with online revenue accounting for over 95% in recent years, while offline revenue remains below 1 billion RMB [13][14]. - Marketing expenses are high, with over 50% of revenue spent on marketing, while R&D investment has decreased, leading to questions about the sustainability of its competitive edge [14][15]. Industry Context - The current IPO climate in Hong Kong is competitive, with many consumer brands rushing to list, reflecting a broader trend of domestic companies seeking capital through public offerings [16][18]. - The Hong Kong Stock Exchange has over 350 companies in the IPO pipeline, indicating a robust interest in market entry despite regulatory challenges [18].

据招股书显示，在科研平台和体系建设上，截至2025年9月30日，公司研发团队规模达103人，专业背景横跨皮肤学、医学、细胞生物学及合成生物学等多个 学科，形成了跨学科协同攻关的能力。这种投入直接反映在基础研究的沉淀上，截至2025年12月31日，HBN累计发表SCI国际期刊论文50余篇，其中以第一 作者身份发表的论文数量计，HBN在国产护肤品牌中排名第一。 在国货美妆品牌纷纷寻求差异化竞争优势的当下，功效护肤品牌HBN母公司——深圳护家科技（集团）股份有限公司正式向港交所递交上市申请，引发市 场关注。其招股书所展示的发展路径，凸显了一条以深度科研与严谨验证为双核驱动的成长逻辑，为行业提供了从"成分宣称"迈向"证据支撑"的转型观察样 本。 科研驱动创新：构建系统性研发体系 据公开资料显示，HBN创立于2019年，自创立之初便将"让真功效名副其实"作为品牌理念，并笃行"慢科研"的长期主义发展道路。这一理念并非停留于口 号，而是通过构建一套覆盖基础研究、原料创新与产品转化的系统性研发体系来落实。 在"成分"竞争日益同质化的背景下，建立超越营销的信任成为关键。HBN的策略是将"真功效"置于可验证、可追溯的实证体系中， ...

Core Viewpoint - HBN's parent company, Shenzhen Hujia Technology Co., Ltd., has officially submitted an application for a mainboard listing on the Hong Kong Stock Exchange, indicating a continued interest in the Chinese skincare market and the potential for growth in domestic brands [1]. Group 1: Company Overview - HBN is recognized as the youngest player among the top ten domestic skincare brands in China, rapidly rising due to its "early C, late A" product strategy and precise online marketing [5]. - The company was founded in 2019 and has quickly established itself with a focus on "true efficacy," achieving significant market presence in the skincare sector [7]. Group 2: Financial Performance - Hujia Technology's total revenue is projected to increase from 1.948 billion RMB in 2023 to 2.083 billion RMB in 2024, reflecting a growth rate of 6.9%. For the first three quarters of 2025, revenue reached 1.514 billion RMB, a year-on-year increase of 10.2% [9]. - The net profit for 2023, 2024, and the first three quarters of 2025 is reported as 39 million RMB, 129 million RMB, and 145 million RMB, respectively, with a remarkable increase of 232.5% in 2024 compared to 2023 [9]. Group 3: Product and Market Strategy - HBN's primary revenue source is from "improvement-type skincare products," contributing approximately 80% of total revenue in recent years, with a steady increase in the share of "maintenance-type skincare products" [10]. - The company has a high repurchase rate and has seen its net profit double over three years, indicating strong customer loyalty and product effectiveness [7]. Group 4: Sales Channels and Marketing - Hujia Technology's sales are heavily concentrated online, with online channel revenue accounting for 98.6%, 97.7%, and 95.1% of total revenue in 2023, 2024, and the first three quarters of 2025, respectively [12]. - The reliance on online sales has led to high sales expense ratios, with sales and distribution expenses reaching 1.268 billion RMB, 1.238 billion RMB, and 871 million RMB, representing 65.1%, 59.4%, and 57.6% of total revenue [14]. Group 5: Research and Development - Despite HBN's emphasis on "true efficacy," the company's R&D investment is relatively low, with expenditures of 66 million RMB, 58 million RMB, and 40 million RMB for 2023, 2024, and the first three quarters of 2025, respectively, resulting in a decreasing R&D expense ratio [18]. - The majority of Hujia Technology's products are produced through contract manufacturing, raising questions about the extent of its proprietary technology and innovation capabilities [18][24].